Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells

Clinical Cancer Research

Volumn 10, Issue 24, 2004, Pages 8687-8696

  Yeo, Marie ^a   Kim, Dong Kyu ^a   Kim, Young Bae ^a   Oh, Tae Young ^a   Lee, Jong Eun ^a   Cho, Sung Won ^a   Kim, Hugh Chul ^a   Hahm, Ki Baik ^a,b  

^a Ajou University School of Medicine   (South Korea)

^b Ajou University Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

GENOMIC DNA; HEAT SHOCK PROTEIN 27; HEAT SHOCK PROTEIN 70; LANSOPRAZOLE; OMEPRAZOLE; PANTOPRAZOLE; PROTON PUMP INHIBITOR;

ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CELL DEATH; CELL VIABILITY; CONTROLLED STUDY; DNA DAMAGE; DRUG EFFECT; DRUG MECHANISM; DRUG SELECTIVITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; STOMACH CANCER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ANIMALS; ANNEXIN A5; ANTI-ULCER AGENTS; APOPTOSIS; BENZIMIDAZOLES; BIOLOGICAL TRANSPORT; ENZYME ACTIVATION; FIBROBLASTS; H(+)-K(+)-EXCHANGING ATPASE; HEAT-SHOCK PROTEINS; HUMANS; IN SITU NICK-END LABELING; INTESTINAL MUCOSA; MICE; MICE, NUDE; MITOGEN-ACTIVATED PROTEIN KINASES; OMEPRAZOLE; PROTON PUMPS; RATS; STOMACH NEOPLASMS; SULFOXIDES; TRANSPLANTATION, HETEROLOGOUS; TUMOR CELLS, CULTURED;

EID: 11144226693     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-04-1065     Document Type: Article

References (54)

1. Scott DR, Helander HF, Hersey SJ, Sachs G. The site of acid secretion in the mammalian parietal cell. Biochim Biophys Acta Bio-Membr 1993;1146:73-80.
2. +-adenosinetriphosphatase. Biochemistry 1993;32:2345-55.
3. +-ATPaSe in parietal cells of gastric mucosa in the rabbit. Histochemistry 1992;97:255-61.
4. Horn J. The proton-pump inhibitors: similarities and differences. Clin Ther 2000;22:266-80.
5. Sachs G. Proton pump inhibitors and acid-related diseases. Pharmacotherapy 1997;17:22-37.
6. +-ATPase. Ann Rev Pharmacol Toxicol 1995;35:277-305.
7. Fitton A, Wiseman L. Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders. Drugs 1996;51:460-82.
8. Nelson N. Evolution of organellar proton-ATPases. Biochim Biophys Acta 1992;1100:109-24.
9. Nishihara T, Akifusa S, Koseki T, Kato S, Muro M, Hanada N. Specific inhibitors of vacuolar type H (+)-ATPases induce apoptotic cell death. Biochem Biophys Res Commun 1995;212:255-62.
10. Ishisaki A, Hashimoto S, Amagasa T, Nishihara T. Caspase-3 activation during the process of apoptosis induced by a vacuolar type H (+)-ATPase inhibitor. Biol Cell 1999;91:507-13.
11. Ohta T, Arakawa H, Futagami F, et al. Bafilomycin A1 induces apoptosis in the human pancreatic cancer cell line Capan-1. J Pathol 1998;185:324-30.
12. Aiko K, Tsujisawa T, Koseki T, et al. Involvement of cytochrome c and caspases in apoptotic cell death of human submandibular gland ductal cells induced by concanamycin A. Cell Signalling 2002;14:717-22.
13. Franklin RA, McCubrey JA. Kinases: positive and negative regulators of apoptosis. Leukemia 2000;14:2019-34.
14. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002;298:1911-2.
15. Ballif BA, Blenis J. Molecular mechanisms mediating mammalian mitogen-activated protein (MAPK) Kinase (MEK)-MAPK cell survival signals. Cell Growth Differ 2001;12:397-408.
16. Dent P, Jarvis WD, Birrer MJ, et al. The roles of signaling by the p42/p44 mitogen-activated protein (MAP) kinase pathway; a potential route to radio- and chemo-sensitization of tumor cells resulting in the induction of apoptosis and loss of clonogenicity. Leukemia 1998;12:1843-50.
17. Garrido C, Gurbuxani S, Ravagnan L, Kroemer G. Heat shock proteins: endogenous modulators of apoptotic cell death. Biochem Biophys Res Commun 2001;286:433-42.
18. Mehlen P, Kretz-Remy C, Preville X, Arrigo AP. Human hsp27, Drosophila hsp27 and human alpa B-crystallin expression-mediated increase in glutathione is essential for the protective activity of these proteins against TNFalpha-induced cell death. EMBO J 1996;15:2695-706.
19. Garrido C, Bruey JM, Fromentin A, Hamman A, Arrigo AP, Solary E. Hsp27 inhibits cytochrome c-dependent activation of procaspase-9. FASEB J 1999;13:2061-70.
20. Bruey JM, Ducasse C, Bonniaud P, Ravagnan L, Susin SA, Diaz-Latoud C. Hsp27 negatively regulates cell death by interacting with cytochrome C. Nat Cell Bio 2000;2:645-52.
21. Mosser DD, Caron AW, Bourget L, Denis-Larose C, Massie B. Role of human heat shock protein70 in protection against stress-induced apoptosis. Mol Cell Biol 1997;17:5317-27.
22. Buzzard KA, Giaccia AJ, Killender M, et al. Heat shock protein 72 modulates pathways of stress-induced apoptosis. J Biol Chem 1998;273:17147-53.
23. Beere HM, Wolf BB, Chain K, Cohen GM, Green D. Heat shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Biol 2000;2:469-75.
24. Tsukiml Y, Okabe S. Recent advances in gastrointestinal pathophysiology:role of heat shock proteins in mucosal defense and ulcer healing. Biol Pharm Bull 2001;24:1-9.
25. Rokutan K. Gastric mucosal protection and cell proliferation: role of heat shock proteins in gastric mucosal protection. J Gast Hepatology 2000;15:D12-9.
26. Ethridge RT, Hellmich MR, Dobois RN, Evers BM. Inhibition of heat-shock protein 70 induction in intestinal cell overexpressing cyclooxygenase 2 1998;115:1454-63.
27. Shichijo K, Ihara M, Matsuu M, Ito M, Okumura Y, Sekine I. Overexpression of heat shock protein 70 in stomach of stress-induced gastric ulcer-resistant rats. Dig Dis Sci 2003;48:340-8.
28. Stubbs M, McSheeh PM, Griffiths JR. Causes and consequences of acidic pH in tumors: a magnetic resonance study. Adv Enzyme Regul 1999;39:13-30.
29. Helmlinger G, Yuan F, Dellian M, Jain RK. Interstitial pH and pO2 gradients in solid tumor in vivo: high resolution measurements reveal a lack of correlation. Nat Med 1997;3:177-82.
30. 31P MRS as a method of measuring pH in rat tumors. NMR Biomed 1992;5:351-9.
31. Suubbs M, Rodrigues LM, Howe FA, et al. The methabolic consequences of a reversed pH gradient in rat tumors. Cancer Res 1994;54:4011-6.
32. Frenzel T, Kohler S, Bauer H, Niedballa U, WeinMann HJ. Non-invasive in vivo measurements using a fluorinated pH probe and fluorine-19 magnetic resonance spectroscopy. Invest Radiol 1994;29: S220-2.
33. 31PMRS measurements of extracellula pH of tumor using 3-aminopropylphosphonate. Am J Physiol 1994;267:C195-203.
34. 31P MRS in murine tumors. Br J Cancer 1995;72:905-11.
35. Tannock IF, Rotin D. Acid pH in tumors and its potential for therapeutic exploitation. Cancer Res 1989;49:4373-84.
36. + ATPases are functionally expressed in plasma membranes of human tumor cells. Am J Physiol 1993;265:C1015-29.
37. Lee AH, Tannock IF. Heterogeneity of intracellular pH and of mechanisms that regulate interacellular pH in populations of culture cells. Cancer Res 1998;58:1901-8.
38. Namkung W, Lee JA, Ahn W, et al. Ca2 activates cystic fibrosis transmembrane conductance regulator- and Cl- -dependent HCO3 transport in pancreatic duct cells. J Bio Chem 2003;278:200-7.
39. Warburg O. The metabolism of tumors. Arnold Constable London 1930.
40. Holm E, Hagmuller E, Staedt U, et al. Substrate balances across colonic carcinomas in humans, Cancer Res 1995;55:1373-8.
41. Vaupel P, Kallinowski F, Okunieff P. Blood flow, oxygen and nutrient supply, the metabolic microenvironment of human tumors: a review, Cancer Res 1989;49:6449-65.
42. + exchange: structure, regulation, and its role in heart disease. Circ Res 1999;85:777-86.
43. + exchangers. Physiol Rev 1997;77:51-74.
44. +-ATPaSe: A universal proton pump of eukaryotes. Biochem J 1997;324:697-712.
45. Bowman EJ, Siebers A, Altendorf K. Bafilomycin: a class of inhibitors of membrane ATPase from microorganisms, animal cells, and plant cells. Proc Natl Acad Sci USA 1988;85:7972-6.
46. +-ATPase from mammalian kidney. J Biol Chem 1992;267:14539-42.
47. Drose S, Bindseil KU, Bowman EJ, Siebers A, Zeeck A, Altendrof K. Inhibitory effect of modified bafilimycins and concanamycins on P- and V-type adenosinetriphosphatases. Biochemistry 1993;32:3902-6.
48. +-ATPase inhibitor in B lineage cells. J of Cellular Physiology 2002;186:65-72.
49. Erickson KL, Beutler JA, Cardellina II, Boyd MR. Salicylihalamides A and B, Novel Cytotoxic Macrolides from the Marine Sponge Haliclona sp. J Org Chem 1997;62.
50. Boyd MR, Farina C, Belfiore P, et al. Discovery of a novel antitumor benzolactone enamide class that selectively inhibits mammalian vacuolar-type (H+)-atpases. J Pharmacol Exp Ther 2001;297:114-20.
51. Schwerdt G, Freudinger R, Schuster C, Silbernagl S, Gekle M. Inhibition of mitochondria prevents cell death in kidney epithelial cells by intra- and extracellular acidification. Kidney Int 2003;63:1725-35.
52. Matsuyama S, Xu Q, Velours J, Reed JC. The Mitochondrial F0F1-ATPase proton pump is required for function of the proapoptotic protein Bax in yeast and mammalian cells. Mol Cell 1998;1:327-36.
53. Shchepina LA, Pletjushkina OY, Avetisyan AV, et al. Oligomycin, inhibitor of the F0 part of H+-ATP-synthase, suppresses the TNF-induced apoptosis. Oncogene 2002;21:8149-57.
54. Torigoe T, Izumi H, Ise T, et al. Vacuolar H(+)-ATPase: functional mechanisms and potential as a target for cancer chemotherapy. Anticancer Drugs 2002;13:237-43.